Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Maximize your trial’s chances of success with best-in-class clinical trial data and benchmarks.
An effective clinical drug development program strategy requires optimal trial protocol development, operations planning and execution and a clear understanding of the clinical trial landscape. To support success and understand the competition, you need access to relevant, timely clinical trial data and trial benchmarks.
You also need to know where you can find reliable details of competitor and comparator trials as well as information on investigators and sites.
How we can help
It can be very time-consuming to source, review, and analyze available clinical trial data. Parsing through large amounts of information to find the relevant and key insights can also be a frustrating task.
Our easy-to-use products help you quickly filter thousands of trials to find the most relevant set to inform your trial and program strategy – from protocol design to country and principal investigator selection.
We’ll also help you:
Approximately 400,000 investigators in over 170 countries, all with clinical trial experience, all at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove, now on a sleek, modern interface for simpler, faster and more efficient searching.
Key benefits:
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Key benefits:
Citeline
By Heidi Chen 01 Feb 2019
Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.
Topic Drug review
Citeline
01 Feb 2019
With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.
Topic Drug approval Drug review
Sitetrove
07 Jan 2019
Find the right investigators and sites for your clinical trials. For the pharma industry’s most accurate and comprehensive investigator and site intelligence, turn to the invaluable data in Sitetrove. Sitetrove’s team of expert analysts continuously scour over 43,000 public sources to update curated information on the global clinical trial landscape, with content tailored to specific therapeutic areas. Save time and avoid costly delays: find the right investigators in the geographic areas that suit your needs with Sitetrove.
Citeline
By Doro Shin 23 Nov 2018
A clinical review of the competitive landscape, approved therapies, trial outcomes and experienced investigators in this highly targeted space.
Topic Cancer
Citeline, Citeline Analytics
By Laura Runkel 08 Nov 2018
For a deeper look into the data behind last year’s completed clinical trials and the trends driving them, Listen to the Completed Clinical Trials 2017: Status Quo or No?
Topic Clinical trials
Trialtrove
By Doro Shin 08 Nov 2018
For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.
Topic Clinical trials
Citeline
By Pippa Nutkins 05 Nov 2018
Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.
Trialtrove
By Christine Blazynski, PhD 19 Oct 2018
As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.
Topic Clinical trials
Citeline, Trialtrove
By Laura Runkel 19 Oct 2018
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
Citeline
By KNect365 28 Aug 2018
Clinical trials are continually evolving, particularly in light of increasing pressures from new technologies and other disruptors. Trends ranging from artificial intelligence (AI) and mHealth to patient-centricity are challenging the industry to innovate against the backdrop of looming regulatory changes and shifting competitor landscapes resulting from M&A activity. In order to explore these trends, KNect365 Life Sciences recently conducted one of the biggest surveys of its kind across clinical trial professionals from within pharma, CROs, sites, service providers, academia and patient groups across the world to look beyond the hype.
Citeline
02 Aug 2018
Citeline’s completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots.
Topic Clinical trials
Pharmaprojects
13 Jul 2018
The discovery and deep investigation of the microbiome has been one of the most significant recent biomedical advances. Extensive research suggests that dysbiosis of the gut microbiome plays a significant role in multiple gastrointestinal (GI) disorders such as; Crohn’s disease, ulcerative colitis, and irritable bowel syndrome (IBS).
Pharmaprojects
13 Jul 2018
Welcome to Pharmaprojects’ roundup of key trends in pharmaceutical R&D in 2018, focusing on five key takeaways from our full annual report
Citeline, Scrip, Biomedtracker, Datamonitor Healthcare
By Mary Jo Laffler 29 May 2018
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.
Topic Clinical trials
Citeline
By Loni Branon 24 May 2018
The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform.
Topic Clinical trials
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
